• Drug Safety Assistance

    United States
    For medical information or to report a side effect/adverse drug experience or quality complaint.
    Ph.: 800.778.7898 (24 hours a day)
    Email: globalpv@mallinckrodt.com

    To report a quality complaint on a drug product or to request medical information on a drug product, you may email the Product Monitoring Department at pmquality@mallinckrodt.com  

    Email: canada.pharmacovigilance@mallinckrodt.com
    Fax: 514.428.8230 or 855.270.7267

    Europe, Middle East and Africa
    Ph.: 00 800 55444777 (24 hours a day, EU and Russia)
    Email: pharmacovigilance-emea@mallinckrodt.com

    Latin America
    Email: pv-latam@mallinckrodt.com


    The Mallinckrodt Pharmacovigilance Department is a group of healthcare professionals responsible for the collection, processing and analysis of adverse events for Mallinckrodt's dosage pharmaceutical, contrast media and nuclear medicine product lines in compliance with regulatory requirements. The goals of the Pharmacovigilance Department are to minimize or prevent harm to patients by identifying new safety concerns and/or hazards associated with Mallinckrodt products and to implement risk-minimization measures when appropriate. You may contact Pharmacovigilance by phone at 800.778.7898 or via e-mail at globalpv@mallinckrodt.com
    The Medical Information Department consists of healthcare professionals (HCPs) who provide responses globally to requests for medical information from prescribers, pharmacists, other HCPs, patients, administrators, institutions and law enforcement. You may contact Medical Information by phone at 800.778.7898, by facsimile at 314.654.3755 or by email at medinfo@mallinckrodt.com
    The Mallinckrodt Product Monitoring Department consists of healthcare and life science professionals responsible for handling the following compliance and U.S. Food and Drug Administration-regulated activities:

    • Maintaining the call center for product monitoring, drug safety and medical information
    • Capturing, documenting, analyzing and reviewing quality complaints for Mallinckrodt's dosage pharmaceutical, contrast media, nuclear medicine, active pharmaceutical ingredients and imaging device product lines
    • Coordinating quality complaint investigations
    • Coordinating and executing product recalls and field actions
    • Fielding and responding to requests for technical and medical information about nuclear medicine, contrast media, imaging device and dosage pharmaceutical products

    You may contact us by telephone at 800.778.7898 or via e-mail at pmquality@mallinckrodt.com

    Branded Pharmaceuticals

    To report an adverse event or a product complaint or if you have a medical inquiry, please call 800.778.7898.

    For questions or comments about pain products marketed through our Specialty Pharmaceuticals Brands segment, please complete the form below and indicate your area of interest.

    Send Us An Email

    United States Customer Service
    Ph. 800.325.8888
    Fx. 314.654.6511

    Global Customer Service
    Ph. 314.654.6010
    Fx. 314.654.6852




    Generic Pharmaceuticals

    Generics Customer Service

    Order Information

    Our highly responsive customer service department can assist you in placing your orders by phone, fax, mail and EDI. Please note that all Mallinckrodt products are shipped in case quantities only. Minimum order amount is $300.00.

    Customer Service Toll-Free No.: 800.325.8888

    Fax No.: 800.323.5039

    Mailing Address

    Mallinckrodt LLC 
    Attn: Dosage Pharmaceuticals - Customer Service 
    675 McDonnell Blvd. 
    St. Louis, MO 63042

    Send Us An Email


    Customer Service Hours

    Monday through Friday, 7:30 am to 4:30 pm CST.

    Customer Support Services are available to assist you with billing, credit, returns and shipment schedule inquiries and procedures.

    Concealed Shipment Damage/Losses

    Damage/loss claims must be documented upon delivery and reported directly to Mallinckrodt’s Customer Service Group at 800.325.8888 within 10 days of purchase. The U.S. Drug Enforcement Administration recommends that all customers open and inventory all shipments as soon as possible. Failure to report these damages/Iosses in a timely manner significantly impairs Mallinckrodt’s ability to properly investigate the cause of the damage or loss. Any damage or loss reported to Mallinckrodt more than 10 days after receipt by the customer will not be eligible for credit.

    Shipments and Warehouse Facility

    Our distribution center is located in our pharmaceuticals manufacturing and packaging facility at 172 Railroad Avenue, Hobart, NY, 13788. This shipping facility is a state-of-the-art distribution center which will enhance our daily shipping efficiency and provide better service for our customers’ product orders and scheduling needs.

    Our distribution center ships products five days a week, Monday through Friday. Methadone products ship to treatment clinics Monday through Thursday.

    Product Monitoring

    The Product Monitoring Department consists of healthcare and life science professionals with responsibility for the following activities:

    • Capture, document, analyze and review Quality complaints for Mallinckrodt’s Pharmaceutical products.
    • Coordinate Quality complaint investigations.
    • Field and respond to technical and medical information requests for Mallinckrodt’s Pharmaceutical products.  

    If you would like to report a quality issue, you may contact us by phone at 800.778.7898 or via email.

    Drug Safety

    The Pharmacovigilance Department consists of healthcare professionals who are responsible globally for the collection, processing, and analysis of adverse events for Mallinckrodt’s Dosage Pharmaceutical, Contrast Media, and Nuclear Medicine product lines in compliance with regulatory requirements. Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem. The goal of our department is to minimize or prevent harm to our patients by identifying new safety concerns and/or hazards associated with Mallinckrodt products and to implement risk minimization measures when appropriate.

    If you would like to report an adverse event, you may contact us by phone at 800.778.7898 or via email.


    Active Pharmaceutical Ingredients

    Please contact Active Pharmaceutical Ingredients at Mallinckrodt Pharmaceuticals using the phone number or email contact form below.

    Ph. 1.800.895.9048

    Send Us An Email

    Global Medical Imaging


    U.S. Customer Service 
    Ph.  888.744.1414 option 1 then option 2
    Fx.  888.744.4646
    Business Hours:  Monday – Friday 7:00 a.m. to 5:00 p.m. CST
    Send Us An Email

    U.S. Local Mallinckrodt Representative

    U.S. Contrast Media & Devices

    U.S. Product Monitoring, Drug Safety and Medical Information   
    To report a product quality complaint, adverse event or to request medical information, please contact:
    Ph. 800.778.7898
    Outside USA: 314.654.5737
    Fx. 314.654.8206
    Email: productmonitoringhazelwood@mallinckrodt.com

    Business Hours:  Monday – Friday 7:00 a.m. to 5:00 p.m. CST

    U.S. Headquarters
    Mallinckrodt Pharmaceuticals
    675 McDonnell Boulevard
    St. Louis, MO 63042

    Asia Pacific
    Mallinckrodt Pharmaceuticals
    Unit 01-02, 12-20, Level 20, Tower 1, Grand Century Place
    193 Prince Edward Road West
    Kowloon, Hong Kong
    +852 3183 1500

    Europe Middle East and Africa
    Mallinckrodt Pharmaceuticals
    Hinterbergstasse 20
    6330 Cham,
    +41 41 747 4646

    Latin America
    Mallinckrodt Pharmaceuticals
    675 McDonnell Blvd.
    St. Louis, MO 63042 (USA)
    Mallinckrodt Japan Co. Ltd.
    4-14, Koraku 1-chrome,
    Bunkyo-ku, Tokyo 112-004
    +81 3 3830 7146

    Requests for Commercial Support Commercial Support Button






  • Board of Directors

    For confidential or anonymous communication, use the toll-free number: 888.696.9864

    For all other communication, please use this form.

    Mailing Address:
    Office of the General Counsel
    675 McDonnell Blvd.
    St. Louis, MO 63042

    Business Development & Licensing

    Rick Hoyt
    Vice President, Business Development & Licensing

    Send Us An Email


    For more information about careers at Mallinckrodt Pharmaceuticals, please visit the Careers section of our website.

    Careers Button

    Compliance & Business Integrity

    Raymond Furey
    Chief Compliance Officer
    675 McDonnell Blvd.
    Hazelwood, MO 63042

    For the ability to report concerns about Mallinckrodt's business practices, please feel free to contact our Integrity Hotline at (888) 696-9864. For areas outside of the United States and Canada, please click here for country access codes and dialing information using ATT Direct Access Service.

    You may also click here to access the Integrity Helpline website for the EU and here for the rest of the world, including the United States.

    Download the Mallinckrodt Guide to Business Conduct. 

    Media Relations

    Rhonda Sciarra
    Corporate Communications Manager
    Ph. 314.654.2000

    News & Media Page

    Requests for Commercial Support

    Submit a request for funding scientific, educational and community programs.

    Commercial Support Button


    The purchasing organization at Mallinckrodt Pharmaceuticals is committed to creating mutually beneficial supply-base relationships to assist in delivering excellence in product quality and service to our customers.

    Click here to complete our Supplier Inquiry Form.

  • Principal Executive Office   U.S. Headquarters  
    Mallinckrodt plc
    Damastown Industrial Estate
    Mulhuddart, Dublin 15

    Ph. +353 1 8808180
      675 McDonnell Blvd.
    St. Louis, MO 63042

    Ph. 314.654.2000